{"id":"https://openalex.org/W1993685338","doi":"https://doi.org/10.1158/1538-7445.am2014-4892","title":"Abstract 4892: PYK2 mediates microenvironment-specific myeloma survival","display_name":"Abstract 4892: PYK2 mediates microenvironment-specific myeloma survival","publication_year":2014,"publication_date":"2014-10-01","ids":{"openalex":"https://openalex.org/W1993685338","doi":"https://doi.org/10.1158/1538-7445.am2014-4892","mag":"1993685338"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2014-4892","doi":"https://doi.org/10.1158/1538-7445.am2014-4892","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2014-4892","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5014350127","display_name":"Mark B. Meads","orcid":"https://orcid.org/0009-0008-0259-1875","observed_orcids":["https://orcid.org/0009-0008-0259-1875"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark B. Meads","raw_affiliation_strings":["1H. Lee Moffitt Cancer Center & Res. Institute, Tampa, FL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1H. Lee Moffitt Cancer Center & Res. Institute, Tampa, FL;","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076672524","display_name":"Bin Fang","orcid":"https://orcid.org/0000-0002-7636-1318","observed_orcids":["https://orcid.org/0000-0002-7636-1318","https://orcid.org/0000-0003-0506-2932"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bin Fang","raw_affiliation_strings":["1H. Lee Moffitt Cancer Center & Res. Institute, Tampa, FL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1H. Lee Moffitt Cancer Center & Res. Institute, Tampa, FL;","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110324556","display_name":"Linda Mathews","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Linda Mathews","raw_affiliation_strings":["1H. Lee Moffitt Cancer Center & Res. Institute, Tampa, FL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1H. Lee Moffitt Cancer Center & Res. Institute, Tampa, FL;","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001167914","display_name":"Jennifer Y. Gemmer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jennifer Gemmer","raw_affiliation_strings":["1H. Lee Moffitt Cancer Center & Res. Institute, Tampa, FL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1H. Lee Moffitt Cancer Center & Res. Institute, Tampa, FL;","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103509083","display_name":"Liang Nong","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Liang Nong","raw_affiliation_strings":["1H. Lee Moffitt Cancer Center & Res. Institute, Tampa, FL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1H. Lee Moffitt Cancer Center & Res. Institute, Tampa, FL;","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080859243","display_name":"Robert MacCleod","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800035258","display_name":"Ionis Pharmaceuticals (United States)","ror":"https://ror.org/00t8bew53","country_code":"US","type":"company","lineage":["https://openalex.org/I2800035258"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert MacCleod","raw_affiliation_strings":["2ISIS Pharmaceuticals, Carlsbad, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2ISIS Pharmaceuticals, Carlsbad, CA","institution_ids":["https://openalex.org/I2800035258"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054463097","display_name":"Lori Hazlehurst","orcid":"https://orcid.org/0000-0001-7040-4084","observed_orcids":["https://orcid.org/0000-0001-7040-4084"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lori Hazlehurst","raw_affiliation_strings":["1H. Lee Moffitt Cancer Center & Res. Institute, Tampa, FL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1H. Lee Moffitt Cancer Center & Res. Institute, Tampa, FL;","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002876951","display_name":"John M. Koomen","orcid":"https://orcid.org/0000-0002-3818-1762","observed_orcids":["https://orcid.org/0000-0002-3818-1762"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John Koomen","raw_affiliation_strings":["1H. Lee Moffitt Cancer Center & Res. Institute, Tampa, FL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1H. Lee Moffitt Cancer Center & Res. Institute, Tampa, FL;","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5053572690","display_name":"Kenneth H. Shain","orcid":"https://orcid.org/0000-0003-4178-8888","observed_orcids":["https://orcid.org/0000-0003-4178-8888"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kenneth H. Shain","raw_affiliation_strings":["1H. Lee Moffitt Cancer Center & Res. Institute, Tampa, FL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1H. Lee Moffitt Cancer Center & Res. Institute, Tampa, FL;","institution_ids":["https://openalex.org/I3019308854"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"74","issue":"19_Supplement","first_page":"4892","last_page":"4892"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10831","display_name":"Cell Adhesion Molecules Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2723","display_name":"Immunology and Allergy"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11503","display_name":"Cytokine Signaling Pathways and Interactions","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/k2","display_name":"K2","score":0.703000009059906},{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.9779999852180481},{"id":"https://openalex.org/keywords/bone-marrow-microenvironment","display_name":"bone marrow microenvironment","score":0.8870000243186951},{"id":"https://openalex.org/keywords/interleukin-6","display_name":"interleukin-6","score":0.7739999890327454},{"id":"https://openalex.org/keywords/stat3-signaling","display_name":"STAT3 signaling","score":0.8130000233650208},{"id":"https://openalex.org/keywords/beta1-integrin","display_name":"beta1 integrin","score":0.8320000171661377},{"id":"https://openalex.org/keywords/fibronectin-adhesion","display_name":"fibronectin adhesion","score":0.984000027179718},{"id":"https://openalex.org/keywords/focal-adhesions","display_name":"focal adhesions","score":0.9100000262260437},{"id":"https://openalex.org/keywords/gp130","display_name":"gp130","score":0.8880000114440918},{"id":"https://openalex.org/keywords/jak1","display_name":"JAK1","score":0.9810000061988831},{"id":"https://openalex.org/keywords/mesenchymal-stem-cells","display_name":"mesenchymal stem cells","score":0.8840000033378601},{"id":"https://openalex.org/keywords/measurable-residual-disease","display_name":"minimal residual disease","score":0.9160000085830688},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.7070000171661377},{"id":"https://openalex.org/keywords/myeloma-cell-survival","display_name":"myeloma cell survival","score":0.6420000195503235},{"id":"https://openalex.org/keywords/autophosphorylation","display_name":"autophosphorylation","score":0.6710000038146973}],"concepts":[{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.650478720664978},{"id":"https://openalex.org/C16930146","wikidata":"https://www.wikidata.org/wiki/Q4381253","display_name":"Stromal cell","level":2,"score":0.573120653629303},{"id":"https://openalex.org/C151166631","wikidata":"https://www.wikidata.org/wiki/Q904514","display_name":"Focal adhesion","level":3,"score":0.5242643356323242},{"id":"https://openalex.org/C195687474","wikidata":"https://www.wikidata.org/wiki/Q409715","display_name":"Integrin","level":3,"score":0.49581727385520935},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.4873872399330139},{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.48021015524864197},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.45710429549217224},{"id":"https://openalex.org/C85789140","wikidata":"https://www.wikidata.org/wiki/Q187640","display_name":"Cell adhesion","level":3,"score":0.4319199323654175},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4319159686565399},{"id":"https://openalex.org/C11960822","wikidata":"https://www.wikidata.org/wiki/Q242736","display_name":"Phosphorylation","level":2,"score":0.41326069831848145},{"id":"https://openalex.org/C2777553839","wikidata":"https://www.wikidata.org/wiki/Q14330986","display_name":"Tyrosine phosphorylation","level":3,"score":0.4104093909263611},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.35653460025787354},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.20272359251976013},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.10214707255363464},{"id":"https://openalex.org/C3020616263","wikidata":"https://www.wikidata.org/wiki/Q1216998","display_name":"Tumor cells","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2014-4892","doi":"https://doi.org/10.1158/1538-7445.am2014-4892","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2014-4892","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2892729194","https://openalex.org/W2514179306","https://openalex.org/W2180166599","https://openalex.org/W2574316212","https://openalex.org/W4244707967","https://openalex.org/W2578712640","https://openalex.org/W2082726173","https://openalex.org/W2601367563","https://openalex.org/W1437526066","https://openalex.org/W2008309108"],"abstract_inverted_index":{"Abstract":[0],"Multiple":[1],"myeloma":[2,102,196,289,346,399],"remains":[3],"an":[4],"incurable":[5],"malignancy":[6],"due":[7],"to":[8,52,74,130,175,199,243,313],"the":[9,12,36,94,111,136,152,176,209,219,226,263,280,331,359,405,410],"influence":[10],"of":[11,28,39,43,87,97,110,179,193,211,247,277,282,306,330,338,361,404,409],"bone":[13,202,294],"marrow":[14,203,295],"microenvironment":[15],"on":[16],"survival,":[17],"drug":[18,54],"response,":[19],"and":[20,41,59,63,77,135,151,165,214,225,236,274,302,335,364],"resultant":[21],"minimal":[22],"residual":[23],"disease":[24],"(MRD).":[25],"Therefore,":[26],"identification":[27],"microenvironment-specific":[29,398],"survival":[30,354],"signaling":[31,69,221,245,310,323],"determinants":[32],"is":[33],"critical":[34],"for":[35,413],"rationale":[37],"design":[38],"therapy":[40],"elimination":[42],"MRD.":[44,373],"The":[45],"pleiotropic":[46],"cytokine":[47,250,269],"IL-6":[48,227],"has":[49,240,253],"been":[50,241,255],"shown":[51,66],"mediate":[53],"resistance":[55],"in":[56,101,142,285,324,344,372],"both":[57],"solid":[58],"hematopoietic":[60],"tumors.":[61],"We":[62,90,216],"others":[64],"have":[65,91],"that":[67,218,317],"collaborative":[68,220],"between":[70,222],"\u03b21":[71,223,303],"integrin-mediated":[72],"adhesion":[73,129,170,198],"fibronectin":[75],"(FN)":[76],"Interleukin-6":[78],"(IL-6)":[79],"confers":[80],"a":[81,258,351,369],"more":[82,325],"malignant":[83],"phenotype":[84],"via":[85],"amplification":[86,96,210,260,281],"STAT3":[88,99,213,259,283,309,322],"activation.":[89],"since":[92],"validated":[93],"FN-adhesion-dependent":[95],"IL-6-induced":[98,212],"phosphorylation":[100,178,284],"patient":[103,293,314],"specimens":[104],"by":[105,184,233],"flow":[106],"cytometry.":[107],"Further":[108],"characterization":[109],"post-translational":[112],"events":[113,246],"modulated":[114],"under":[115],"these":[116],"culture":[117],"conditions":[118],"with":[119,133,168,208,257,292],"quantitative":[120],"phospho-tyrosine":[121],"profiling":[122],"identified":[123,183],"193":[124],"differentially":[125],"phosphorylated":[126],"peptides":[127],"after":[128],"FN,":[131],"treatment":[132],"IL-6,":[134],"combination.":[137],"Phosphopeptides":[138],"represented":[139],"proteins":[140],"involved":[141],"signal":[143,228],"transduction,":[144],"cytoskeleton":[145],"assembly/adhesion,":[146],"transcription,":[147],"RNA":[148],"processing,":[149],"metabolism,":[150],"cell":[153,197,341],"cycle.":[154],"Seventy-seven":[155],"phosphorylations":[156],"were":[157],"up-regulated":[158],"upon":[159],"adhesion,":[160],"including":[161],"PYK2/FAK2,":[162],"paxillin,":[163],"CASL,":[164],"p130CAS":[166],"consistent":[167],"focal":[169],"(FA)":[171],"formation.":[172],"In":[173],"addition":[174],"enhanced":[177],"PYK2":[180,191,239,278,318,339,366,396],"at":[181],"Y580":[182],"proteomic":[185],"screening,":[186],"western":[187],"blot":[188],"analysis":[189],"demonstrated":[190],"autophosphorylation":[192],"Y402":[194],"following":[195],"FN":[200],"or":[201,266],"stromal":[204,296],"cells":[205,290,297],"(BMSC),":[206],"correlating":[207],"JAK1.":[215],"hypothesized":[217],"integrin":[224],"transducer,":[229],"gp130,":[230],"was":[231],"mediated":[232],"FA":[234],"formation":[235],"PYK2.":[237],"Although":[238],"linked":[242],"downstream":[244],"other":[248],"JAK-dependent":[249],"receptors,":[251],"it":[252],"not":[254],"associated":[256],"mechanism":[261],"within":[262,358],"Type":[264,267],"I":[265],"II":[268],"receptor":[270],"families.":[271],"Both":[272],"pharmacological":[273,336],"molecular":[275,334],"targeting":[276,337],"attenuated":[279],"adhered":[286,312],"cells.":[287,347],"Further,":[288],"co-cultured":[291],"(BMSC)":[298],"showed":[299],"similar":[300],"gp130":[301],"integrin-specific":[304],"enhancement":[305],"PYK2,":[307],"JAK1,":[308],"when":[311],"BMSCs,":[315],"demonstrating":[316],"modulates":[319],"co-stimulation":[320],"specific":[321,370],"complex,":[326],"clinically":[327],"relevant":[328],"models":[329],"microenvironment.":[332],"Importantly,":[333],"induced":[340],"death":[342],"solely":[343],"BMSC-adherent":[345],"These":[348],"data":[349],"identify":[350],"novel":[352],"PYK2-mediated":[353],"pathway":[355],"activated":[356],"only":[357],"context":[360],"microenvironmental":[362],"cues":[363],"suggest":[365],"may":[367],"be":[368],"target":[371],"Citation":[374],"Format:":[375],"Mark":[376],"B.":[377],"Meads,":[378],"Bin":[379],"Fang,":[380],"Linda":[381],"Mathews,":[382],"Jennifer":[383],"Gemmer,":[384],"Liang":[385],"Nong,":[386],"Robert":[387],"MacCleod,":[388],"Lori":[389],"Hazlehurst,":[390],"John":[391],"Koomen,":[392],"Kenneth":[393],"H.":[394],"Shain.":[395],"mediates":[397],"survival.":[400],"[abstract].":[401],"In:":[402],"Proceedings":[403],"105th":[406],"Annual":[407],"Meeting":[408],"American":[411],"Association":[412],"Cancer":[414,425],"Research;":[415],"2014":[416],"Apr":[417],"5-9;":[418],"San":[419],"Diego,":[420],"CA.":[421],"Philadelphia":[422],"(PA):":[423],"AACR;":[424],"Res":[426],"2014;74(19":[427],"Suppl):Abstract":[428],"nr":[429],"4892.":[430],"doi:10.1158/1538-7445.AM2014-4892":[431]},"counts_by_year":[],"updated_date":"2026-09-24T07:57:37.273135","created_date":"2016-06-24T00:00:00"}